VSPARTICLE BV

Their core work

VSParticle is a Delft-based technology SME that develops nanoparticle generation and size-selection instruments. Their core offering is hardware tooling that produces precisely controlled nanoparticles on demand, which researchers and manufacturers use across applications from catalysis to printed electronics. In H2020 projects, they supply nano-ink and nanoparticle production capabilities to consortia working on electronics manufacturing, catalyst development, and health-related nanoparticle research.

What they specialise in

How they've shifted over time

All three of VSParticle's H2020 projects launched in 2019, so the evolution window is narrow. However, the keyword data reveals two distinct application tracks: manufacturing-oriented work (printed electronics, nano-inks, digital pilot production lines) and health/environment-oriented work (nanoparticle toxicology, brain health, inhalation effects). This suggests a company whose core nanoparticle tooling is branching into diverse application domains rather than deepening in one vertical.

VSParticle is expanding from pure manufacturing applications toward health and environmental nanoparticle research, positioning their instruments as cross-domain platform technology.

How they like to work

VSParticle primarily joins consortia as a specialist equipment and materials provider (2 of 3 projects as participant), while also demonstrating initiative through one SME Instrument Phase 1 coordination. With 34 unique partners across 14 countries from just 3 projects, they operate in large, diverse consortia — typical for a technology supplier whose instruments serve multiple research communities.

Despite only three projects, VSParticle has built a broad network of 34 partners across 14 countries, reflecting the wide applicability of their nanoparticle tools. Their base in Delft places them in the heart of the Dutch nanotechnology ecosystem.

What sets them apart

VSParticle occupies a rare niche as a hardware SME that builds the instruments other researchers need to produce and control nanoparticles. Unlike labs that study nanoparticles or companies that sell nanomaterials, they provide the generation and selection tools themselves. This makes them a versatile consortium partner — any project needing precisely controlled nanoparticle production can plug in their technology, regardless of application domain.

Highlights from their portfolio

• LEE-BED
  Largest project by funding (EUR 369K), focused on an innovation test bed for nanomaterial-based embedded electronics — directly showcases their nano-ink production capabilities.
• ModCat
  Their only coordinated project (SME Phase 1), explicitly centered on their core product: a nanoparticle size selection tool for next-generation model catalysts.
• TUBE
  Demonstrates cross-sector versatility — a transport/health project studying nanoparticle effects on brain health, far from their manufacturing origins.